This investigation or therapeutic intervention hasn't proven advantage for sufferers and could be performed only in unique conditions; Based on existing know-how a basic advice can't be providedGermline testing for hereditary breast and ovarian cancer is now more and more relevant not merely for risk-adapted avoidance measures but in addition for t